Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years, especially because patent protection expired outside the U.S. in 2012. In the United States, several drug manufacturers are currently allowed to market generic versions of Viagra (sildenafil), even if the patent is set to expire in 2020. This was the reason behind a further significant decline in sales in 2017-2018.
Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.
Worldwide revenue of Pfizer's Viagra from 2003 to 2019
(in million U.S. dollars)
This statistic was assembled from several of Pfizer's annual and financial reports.
* Viagra lost exclusivity in the U.S. in December 2017. In 2018, revenues for Viagra in the U.S. and Canada, which were reported in IH through 2017, were reported in EH (which reported all other Viagra revenues
excluding the U.S. and Canada through 2017). Therefore, in 2018, total Viagra worldwide revenues were reported in EH. Total Viagra revenues in 2017 and 2016 represented the aggregate of worldwide revenues
from Viagra IH and Viagra EH.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Pfizer. (February 28, 2020). Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars) [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/
Pfizer. "Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars)." Chart. February 28, 2020. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/
Pfizer. (2020). Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars). Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/
Pfizer. "Worldwide Revenue of Pfizer's Viagra from 2003 to 2019 (in Million U.S. Dollars)." Statista, Statista Inc., 28 Feb 2020, https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/
Pfizer, Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars) Statista, https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/ (last visited September 01, 2024)
Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars) [Graph], Pfizer, February 28, 2020. [Online]. Available: https://www.statista.com/statistics/264827/pfizers-worldwide-viagra-revenue-since-2003/